Form 4: Ginkgo Bioworks Director Dekkers Sells Shares at $0.93

Director Marijn E. Dekkers of Ginkgo Bioworks Holdings, Inc. reports the sale of 1,727,056 shares of Class A Common Stock at $0.93 per share on May 14, 2024.

Summary

• On May 14, 2024, Marijn E. Dekkers, a director of Ginkgo Bioworks Holdings, Inc., sold 1,727,056 shares of Class A Common Stock at a price of $0.93 per share.
• Following the transaction, Dekkers directly owns 281,217 shares of Class A Common Stock.
• Dekkers also indirectly owns 5,780,364 shares through Novalis LifeSciences Investments I, L.P., where he serves as the manager of the general partner.
• Included in these holdings are earn-out shares that will vest if Ginkgo's Class A Common Stock achieves certain price targets before September 16, 2026.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative due to the director's stock sale, which could raise concerns about the company's prospects, although the presence of earn-out shares with price-based vesting conditions suggests some confidence in future performance.

Negatives

• A director selling a large number of shares could be perceived negatively by investors.

Risks

• The earn-out shares are contingent on Ginkgo's stock price reaching specific thresholds by September 16, 2026, which may not be achieved.

Future Outlook

The vesting of earn-out shares depends on the future performance of Ginkgo Bioworks' stock price.

Industry Context

This transaction reflects insider activity in the biotechnology sector, which is often scrutinized for its impact on investor confidence.

Comparison to Industry Standards

• Comparing insider trading activity to peers like Amyris or Zymergen (now defunct) can provide context, but each company's situation is unique.
• Generally, insider sales are viewed more negatively than insider purchases, but the reasons behind the sale are important to consider.

Stakeholder Impact

• The stock sale could potentially impact shareholder confidence.
• Employees holding stock options or shares may be concerned about the stock's short-term performance.

Key Dates